ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-0.87%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$556M
AUM Growth
+$556M
Cap. Flow
+$7.31M
Cap. Flow %
1.31%
Top 10 Hldgs %
96.19%
Holding
17
New
1
Increased
2
Reduced
–
Closed
2

Top Buys

1
BBIO icon
BridgeBio Pharma
BBIO
$128M
2
NUVB icon
Nuvation Bio
NUVB
$26.6M
3
MRKR icon
Marker Therapeutics
MRKR
$2.56M

Top Sells

1
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
$148M
2
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$2.01M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$374M 67.28% 6,068,125 +2,078,713 +52% +$128M
HRMY icon
2
Harmony Biosciences
HRMY
$2.12B
$27.8M 5.01% 842,815 – –
NUVB icon
3
Nuvation Bio
NUVB
$1.02B
$26.6M 4.78% +2,541,009 New +$26.6M
SNDX icon
4
Syndax Pharmaceuticals
SNDX
$1.41B
$22.9M 4.13% 1,025,000 – –
SPRB
5
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$20M 3.6% 1,205,511 – –
ACRS icon
6
Aclaris Therapeutics
ACRS
$209M
$16M 2.88% 634,455 – –
SYRE icon
7
Spyre Therapeutics
SYRE
$996M
$13.4M 2.41% 1,691,151 – –
TECX
8
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$12.8M 2.31% 1,009,779 – –
VRNA
9
Verona Pharma
VRNA
$9.16B
$11.1M 2.01% 1,332,485 – –
PSTX
10
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$9.96M 1.79% 1,043,267 – –
MRKR icon
11
Marker Therapeutics
MRKR
$12M
$7.04M 1.27% 3,142,857 +1,142,857 +57% +$2.56M
BCEL
12
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$5.94M 1.07% 387,653 – –
OBSV
13
DELISTED
ObsEva SA Ordinary Shares
OBSV
$4.51M 0.81% 1,386,338 – –
ZSAN
14
DELISTED
Zosano Pharma Corporation
ZSAN
$3.37M 0.61% 2,718,226 – –
NBRV
15
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$317K 0.06% 191,028 – –
VIRX
16
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– – -1,010,000 Closed -$2.01M
EIDX
17
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– – -1,123,630 Closed -$148M